Assessment of the utility of MAIT cells as a biomarker for inflammatory bowel diseases

Assessment of the utility of MAIT cells as a biomarker for inflammatory bowel diseases - A study of MAIT cells as a biomarker in inflammatory bowel diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013847

Enrollment

Registered

2014-04-30

Start date

2014-04-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel diseases

Interventions

sampling

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: IBD patients(mild-severe) Patiens consent to the study.

Exclusion criteria

Exclusion criteria: 1.Severe complecations. 2.Have other autoimmune disorders. 3.Using antithrombotic drugs. 4.Pregnant woman. 5.Judged to be inappropriate to the study.

Design outcomes

Primary

Measure	Time frame
Observe symptoms or endoscopic findings, and examine by comparing the numbers of MAIT cells in peripheral blood and colon tissues.	—

Countries

Japan

Contacts

Public ContactTomoyoshi Shibuya

Juntendo University Gastroenterology

tomoyosi@juntendo.ac.jp03-5802-1060

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026